SCHEMBL367706

SCHEMBL367706

CS(=O)(=O)c1ccc2c(C(N)=O)c3ccccn3c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 2/20 0.41
BAZ2A Q9UIF9 2/20 0.41
BRD9 Q9H8M2 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
APAF1 O14727 1/20 0.41
MAPT P10636 1/20 0.41
G6PD P11413 1/20 0.41
PABPC1 P11940 1/20 0.41
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
UBA2 Q9UBT2 1/20 0.41
EGFR P00533 2/20 0.40
SRC P12931 1/20 0.40
LRRK2 Q5S007 3/20 0.38
CSF1R P07333 1/20 0.37
PTGS2 P35354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367746 0.89 EGFR (0.43) BAZ2BBAZ2ABRD9KDM4EMEN1
SCHEMBL364652 0.88 CA2 (0.40) BAZ2BBAZ2AKDM4EMEN1ALDH1A1
SCHEMBL366998 0.87 HTT (0.46) KDM4EMEN1ALDH1A1KMT2AAPAF1
SCHEMBL365825 0.86 IDO1 (0.48) BAZ2BBAZ2ABRD9KDM4EMEN1
SCHEMBL366740 0.82 KDM4E (0.36) BAZ2BBAZ2AKDM4EMEN1ALDH1A1
SCHEMBL367763 0.81 BAZ2B (0.45) BAZ2BBAZ2AKDM4EMEN1ALDH1A1
SCHEMBL367200 0.80 KDM4E (0.55) BAZ2BBAZ2AKDM4EMEN1ALDH1A1
SCHEMBL367329 0.80 BAZ2B (0.47) BAZ2BBAZ2ABRD9KDM4EMEN1
SCHEMBL367704 0.80 EGFR (0.43) BAZ2BBAZ2AKDM4EMEN1ALDH1A1
SCHEMBL366108 0.79 KMT2A (0.40) BAZ2BBAZ2ABRD9KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed